Literature DB >> 10761989

Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids.

A Chauhan1, I Ray, V P Chauhan.   

Abstract

Fibrillar amyloid beta-protein (Abeta) is the major protein of amyloid plaques in the brains of patients with Alzheimer's disease (AD). The mechanism by which normally produced soluble Abeta gets fibrillized in AD is not clear. We studied the effect of neutral, zwitterionic, and anionic lipids on the fibrillization of Abeta 1-40. We report here that acidic phospholipids such as phosphatidic acid, phosphatidylserine, phosphatidylinositol (PI), PI 4-phosphate, PI 4,5-P2 and cardiolipin can increase the fibrillization of Abeta, while the neutral lipids (diacylglycerol, cholesterol, cerebrosides), zwitterionic lipids (phosphatidylcholine, phosphatidylethanolamine, sphingomyelin) and anionic lipids lacking phosphate groups (sulfatides, gangliosides) do not affect Abeta fibrillization. Abeta was found to increase the fluorescence of 1-acyl-2-[12-[(7-nitro-2-1, 3-benzoxadiazol-4-yl) amino] dodecanoyl]-sn-glycero-3-phosphate (NBD-PA) in a concentration-dependent manner, while no change was observed with 1-acyl-2- [12-[(7-nitro-2-1, 3-benzoxadiazol-4-yl) amino] dodecanoyl]-sn-glycero-3-phosphoethanolamine (NBD-PE). Under similar conditions, other proteins such as apolipoprotein E, gelsolin and polyglutamic acid did not interact with NBD-PA. The order of interaction of amyloid beta-peptides with NBD-PA was Abeta 1-43 = Abeta 1-42 = Abeta 17-42 > Abeta 1-40 = Abeta 17-40. Other Abeta peptides such as Abeta 1-11, Abeta 1-16, Abeta 1-28, Abeta 1-38, Abeta 12-28, Abeta 22-35, Abeta 25-35, and Abeta 31-35 did not increase the NBD-PA fluorescence. These results suggest that phosphate groups, fatty acids, and aliphatic amino acids at the C-terminus end of Abeta 1-40/Abeta 1-42 are essential for the interaction of Abeta with anionic phospholipids, while hydrophilic Abeta segment from 1-16 amino acids does not participate in this interaction. Since positively charged amino acids in Abeta are necessary for the interaction with negatively charged phosphate groups of phospholipids, it is suggested that Lys28 of Abeta may provide anchor for the phosphate groups of lipids, while aliphatic amino acids (Val-Val-Ile-Ala) at the C-terminus of Abeta interact with fatty acids of phospholipids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761989     DOI: 10.1023/a:1007509608440

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  31P nuclear magnetic resonance study of the brain in Alzheimer's disease.

Authors:  J W Pettegrew; J Moossy; G Withers; D McKeag; K Panchalingam
Journal:  J Neuropathol Exp Neurol       Date:  1988-05       Impact factor: 3.685

2.  Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.

Authors:  T Pillot; M Goethals; B Vanloo; C Talussot; R Brasseur; J Vandekerckhove; M Rosseneu; L Lins
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

3.  Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.

Authors:  J McLaurin; T Franklin; A Chakrabartty; P E Fraser
Journal:  J Mol Biol       Date:  1998-04-24       Impact factor: 5.469

4.  Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

Authors:  W E Müller; G P Eckert; K Scheuer; N J Cairns; A Maras; W F Gattaz
Journal:  Amyloid       Date:  1998-03       Impact factor: 7.141

5.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.

Authors:  Z Guan; Y Wang; N J Cairns; P L Lantos; G Dallner; P J Sindelar
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

6.  Hippocampal membrane alteration in Alzheimer's disease.

Authors:  G S Zubenko
Journal:  Brain Res       Date:  1986-10-15       Impact factor: 3.252

7.  In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.

Authors:  O Miatto; R G Gonzalez; F Buonanno; J H Growdon
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

8.  Diphosphoinositide and triphosphoinositide in animal tissues. Extraction, estimation and changes post mortem.

Authors:  R M Dawson; J Eichberg
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

9.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

View more
  30 in total

1.  β-Barrel topology of Alzheimer's β-amyloid ion channels.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ricardo Capone; Ratnesh Lal; Ruth Nussinov
Journal:  J Mol Biol       Date:  2010-10-21       Impact factor: 5.469

Review 2.  Fluorescence spectroscopy of protein oligomerization in membranes.

Authors:  Galyna P Gorbenko
Journal:  J Fluoresc       Date:  2010-04-06       Impact factor: 2.217

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

4.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

5.  AβP1-42 incorporation and channel formation in planar lipid membranes: the role of cholesterol and its oxidation products.

Authors:  Daniela Meleleo; Angela Galliani; Gabriella Notarachille
Journal:  J Bioenerg Biomembr       Date:  2013-04-26       Impact factor: 2.945

6.  Amino acid substitutions [K16A] and [K28A] distinctly affect amyloid β-protein oligomerization.

Authors:  Matjaž Žganec; Nicholas Kruczek; Brigita Urbanc
Journal:  J Biol Phys       Date:  2016-05-07       Impact factor: 1.365

7.  Small liposomes accelerate the fibrillation of amyloid β (1-40).

Authors:  Mayu S Terakawa; Hisashi Yagi; Masayuki Adachi; Young-Ho Lee; Yuji Goto
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

Review 8.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

9.  Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity.

Authors:  Huiyuan Li; Bernhard H Monien; Erica A Fradinger; Brigita Urbanc; Gal Bitan
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

10.  Insertion of Alzheimer's A beta 40 peptide into lipid monolayers.

Authors:  Canay Ege; Ka Yee C Lee
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.